cms_DE: 5
In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.
This data as json, copyable
|
rowid
|
facility_name
|
facility_id
|
address
|
city
|
state
|
zip
|
inspection_date
|
deficiency_tag
|
scope_severity
|
complaint
|
standard
|
eventid
|
inspection_text
|
filedate
|
| 5 |
KENTMERE REHABILITATION AND HEALTHCARE CENTER |
85001 |
1900 LOVERING AVENUE |
WILMINGTON |
DE |
19806 |
2016-07-18 |
329 |
D |
0 |
1 |
Z68211 |
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record reviews and interview, it was determined that the facility failed to have two (R126 and R112) out of 30 Stage 2 sampled resident's drug regimen free from unnecessary medications. The facility failed to monitor the resident's lipid profile periodically as indicated for [MEDICATION NAME], a medication for [MEDICAL CONDITION]. Findings include: The product information for [MEDICATION NAME], last revised 7/2016, stated, . Adult Patients .Since maximal effect of a given dose is seen within 4 weeks, periodic lipid determinations should be performed at this time and dosage adjusted according to the patient's response to therapy and established treatment guidelines . 1. Review of R126's clinical record revealed: R126 was admitted to the facility on [DATE] with [MEDICATION NAME] medication included in her daily medication therapy. Review of R126's clinical record from (MONTH) (YEAR) to (MONTH) 13, (YEAR) lacked evidence of the facility monitoring the resident's response to the [MEDICATION NAME] therapy. In an interview on 7/14/16 at 11:15 AM, E5 (LPN, UM) confirmed the finding. On 7/14/16 at 12:55 PM, a physician's orders [REDACTED]. The facility failed to ensure that R112 was being periodically monitored for the response to the [MEDICATION NAME] medication. Findings were reviewed with E2 (DON) on 7/18/16 at 10:10 AM. 2. Review of R112's clinical record revealed: R112 was admitted to the facility on [DATE] with [MEDICATION NAME] medication included in her daily medication therapy. Review of R112's clinical record from (MONTH) (YEAR) to (MONTH) 13, (YEAR) lacked evidence of the facility monitoring the resident's response to the [MEDICATION NAME] therapy. In an interview on 7/15/16 at 3:32 PM, E5 confirmed the finding that a lipid profile was not performed since (MONTH) (YEAR). The facility failed to ensure that R112 was being periodically monitored for the response to the [MEDICATION NAME] medication. Findings were reviewed with E2 on 7/18/16 at 10:10 AM. |
2020-09-01 |